Guru Ownership Trend
Guru Analysis for Mineralys Therapeutics, Inc. (MLYS)
Mineralys Therapeutics, Inc. (MLYS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $25.76 M.
Top institutional holders include Paul Tudor Jones and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $36.09 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 374.1%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 1.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Mineralys Therapeutics, Inc. (MLYS)
Major holders include Paul Tudor Jones ($19.92 M), Renaissance Technologies (RenTech) ($10.21 M), Cliff Asness ($4.11 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.27 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $36.09 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited MLYS. The total reported sell value was $51.9 M.
Yes, 0 managers opened new positions in MLYS, and 2 increased their existing holdings. The total reported buy value was $15.81 M.